Five Challenges Reshaping Healthcare Revenue Cycle

The Revenue Cycle Management Pressure Shift. | The RCM Pressure Shift

Revenue Cycle Management (RCM) leaders are entering a period in which familiar pressures are converging. A recent Becker's Hospital Review report on healthcare's most dangerous trends captures concerns from health system executives about reimbursement, workforce capacity, payer behavior, artificial intelligence and patient access. For RCM leaders, these are not distant enterprise risks. They show up in clean-claim rates, denials, days in A/R, cost to collect and patient collections.

Five Concerning Trends Reshaping Revenue Cycle Management. | Five Trends Reshaping RCM

1. Reimbursement Is Falling Behind Care Costs.

The financial gap is widening. The American Hospital Association reported that Medicare paid hospitals only 83 cents for every dollar spent on Medicare care in 2023, while hospitals absorbed $130 billion in Medicare and Medicaid underpayments. Its 2026 update also found that hospitals spent $43 billion in 2025 trying to collect payment from insurers for care already delivered. When payment rates lag costs, revenue leakage that once looked tolerable becomes strategically material.

RCM leaders therefore need to protect earned revenue before claims leave the organization. Eligibility, authorization, documentation, coding and charge capture must work as one connected flow. Every preventable correction creates rework, delays cash and consumes capacity that could be used to resolve genuinely complex accounts.

2. Payer Friction Is Becoming Faster And More Automated.

Denials are no longer only a back-end recovery problem. McKinsey reported that 15% of initial claims were denied by the end of 2023, up from 9% in 2016. HFMA has also described payer denials becoming smaller, faster and more sophisticated as automation expands.

The practical response is to move intelligence upstream. Teams should identify recurring root causes by payer, service line, location and workflow step, then convert those findings into front-end edits, documentation prompts and ownership rules. The objective is not simply to appeal more effectively. It is to improve first-pass performance so fewer claims require an appeal at all.

3. Coverage Changes Are Shifting More Risk To Patients.

Coverage disruption, higher deductibles and greater cost sharing are moving more financial responsibility to patients. McKinsey's 2026 healthcare outlook anticipates that Medicaid and Affordable Care Act enrollment changes could increase uncompensated care and reduce provider reimbursement.

That makes patient access a revenue cycle control point. Accurate estimates, timely eligibility checks, financial counseling and convenient payment options can reduce surprises and improve collections. The strongest workflows do not force patients to reconcile conflicting information across scheduling, registration, payer portals and billing. They make the financial journey clear before the balance becomes delinquent.

4. Workforce Constraints Are Exposing Fragile Workflows.

Workforce shortages affect more than staffing expense. They expose processes that rely on tribal knowledge, manual handoffs and individual heroics. McKinsey notes that growing administrative demands stretch scarce revenue cycle resources, while the AHA continues to identify labor as hospitals’ largest expense category.

RCM leaders should standardize work, simplify exception paths and reserve specialized talent for decisions that require judgment. Open accountability is critical here: every handoff needs a named owner, a defined service level and visible evidence of completion. This prevents unresolved work from disappearing between patient access, clinical documentation, coding, billing and follow-up.

5. AI Adoption Is Outpacing Operating Readiness.

AI can accelerate eligibility checks, claim review, work prioritization and appeal preparation. Yet the Becker’s report repeatedly warns against adopting AI without governance, workforce readiness or a clear operating problem. Technology layered onto a broken process can automate inconsistency rather than remove it.

RCM leaders should start with bounded use cases tied to measurable outcomes such as clean-claim rate, authorization turnaround time, denial prevention, productivity or net collections. Human review, auditability and feedback loops should be built into the workflow. The question is not whether a model can produce an output, but whether the operating system can trust, act on and learn from that output.

The Leadership Response Must Connect The Revenue Cycle. | The Leadership Response

These five trends point to one priority: build a revenue cycle that prevents avoidable work, learns across functions and makes performance visible. That requires shared metrics from access through collections, disciplined root-cause correction and clear accountability for the conditions that create denials and delays.

The organizations that respond best will not treat revenue cycle transformation as a collection of isolated projects. They will connect people, process, data and automation around one outcome: getting accurate claims paid correctly and promptly while making the financial experience easier for patients.

A practical starting point is a cross-functional performance review that follows revenue from scheduling to final payment. Instead of reviewing only lagging indicators, leaders can examine where work first becomes incomplete, inaccurate or delayed. That view connects a denial to the missed authorization, documentation gap, coding inconsistency or payer rule that produced it. It also reveals whether automation is removing work or merely moving exceptions to another queue.

The operating cadence matters as much as the dashboard. Weekly root-cause reviews should assign corrective action to the function that can prevent recurrence, while monthly executive reviews should track whether the fix improved first-pass results. This creates open accountability without turning performance management into blame. Leaders can see who owns the next action, what evidence will show completion and whether the intervention produced a durable financial result.